147 related articles for article (PubMed ID: 19206525)
1. Influence of size, surface, cell line, and kinetic properties on the specific binding of A33 antigen-targeted multilayered particles and capsules to colorectal cancer cells.
Cortez C; Tomaskovic-Crook E; Johnston AP; Scott AM; Nice EC; Heath JK; Caruso F
ACS Nano; 2007 Sep; 1(2):93-102. PubMed ID: 19206525
[TBL] [Abstract][Full Text] [Related]
2. Monoclonal antibody-functionalized multilayered particles: targeting cancer cells in the presence of protein coronas.
Dai Q; Yan Y; Ang CS; Kempe K; Kamphuis MM; Dodds SJ; Caruso F
ACS Nano; 2015 Mar; 9(3):2876-85. PubMed ID: 25712076
[TBL] [Abstract][Full Text] [Related]
3. In vitro and in vivo characterization of 177Lu-huA33: a radioimmunoconjugate against colorectal cancer.
Almqvist Y; Steffen AC; Tolmachev V; Divgi CR; Sundin A
Nucl Med Biol; 2006 Nov; 33(8):991-8. PubMed ID: 17127172
[TBL] [Abstract][Full Text] [Related]
4. A phase I trial of humanized monoclonal antibody A33 in patients with colorectal carcinoma: biodistribution, pharmacokinetics, and quantitative tumor uptake.
Scott AM; Lee FT; Jones R; Hopkins W; MacGregor D; Cebon JS; Hannah A; Chong G; U P; Papenfuss A; Rigopoulos A; Sturrock S; Murphy R; Wirth V; Murone C; Smyth FE; Knight S; Welt S; Ritter G; Richards E; Nice EC; Burgess AW; Old LJ
Clin Cancer Res; 2005 Jul; 11(13):4810-7. PubMed ID: 16000578
[TBL] [Abstract][Full Text] [Related]
5. Preliminary report of a phase I study of combination chemotherapy and humanized A33 antibody immunotherapy in patients with advanced colorectal cancer.
Welt S; Ritter G; Williams C; Cohen LS; Jungbluth A; Richards EA; Old LJ; Kemeny NE
Clin Cancer Res; 2003 Apr; 9(4):1347-53. PubMed ID: 12684403
[TBL] [Abstract][Full Text] [Related]
6. Phase I study of anticolon cancer humanized antibody A33.
Welt S; Ritter G; Williams C; Cohen LS; John M; Jungbluth A; Richards EA; Old LJ; Kemeny NE
Clin Cancer Res; 2003 Apr; 9(4):1338-46. PubMed ID: 12684402
[TBL] [Abstract][Full Text] [Related]
7. Targeting cancer cells using PLGA nanoparticles surface modified with monoclonal antibody.
Kocbek P; Obermajer N; Cegnar M; Kos J; Kristl J
J Control Release; 2007 Jul; 120(1-2):18-26. PubMed ID: 17509712
[TBL] [Abstract][Full Text] [Related]
8. Monoclonal antibody CC188 binds a carbohydrate epitope expressed on the surface of both colorectal cancer stem cells and their differentiated progeny.
Xu M; Yuan Y; Xia Y; Achilefu S
Clin Cancer Res; 2008 Nov; 14(22):7461-9. PubMed ID: 19010863
[TBL] [Abstract][Full Text] [Related]
9. Targeting cancer cells: controlling the binding and internalization of antibody-functionalized capsules.
Johnston AP; Kamphuis MM; Such GK; Scott AM; Nice EC; Heath JK; Caruso F
ACS Nano; 2012 Aug; 6(8):6667-74. PubMed ID: 22872125
[TBL] [Abstract][Full Text] [Related]
10. Glycosylation profiles of the human colorectal cancer A33 antigen naturally expressed in the human colorectal cancer cell line SW1222 and expressed as recombinant protein in different insect cell lines.
Joosten CE; Cohen LS; Ritter G; Batt CA; Shuler ML
Biotechnol Prog; 2004; 20(4):1273-9. PubMed ID: 15296462
[TBL] [Abstract][Full Text] [Related]
11. Targeting of cancer cells using click-functionalized polymer capsules.
Kamphuis MM; Johnston AP; Such GK; Dam HH; Evans RA; Scott AM; Nice EC; Heath JK; Caruso F
J Am Chem Soc; 2010 Nov; 132(45):15881-3. PubMed ID: 20977221
[TBL] [Abstract][Full Text] [Related]
12. [Purification of colorectal cancer-associated antigen by immuno-affinity chromatography].
Yang Y; Li Y; Wang XH; Shang P; Wang L; Qian AR; Yao XY; Chen ZN
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2004 May; 20(3):348-51. PubMed ID: 15193236
[TBL] [Abstract][Full Text] [Related]
13. Gold hybrid nanoparticles for targeted phototherapy and cancer imaging.
Kirui DK; Rey DA; Batt CA
Nanotechnology; 2010 Mar; 21(10):105105. PubMed ID: 20154383
[TBL] [Abstract][Full Text] [Related]
14. Serological analysis of human anti-human antibody responses in colon cancer patients treated with repeated doses of humanized monoclonal antibody A33.
Ritter G; Cohen LS; Williams C; Richards EC; Old LJ; Welt S
Cancer Res; 2001 Sep; 61(18):6851-9. PubMed ID: 11559561
[TBL] [Abstract][Full Text] [Related]
15. Uptake and intracellular fate of disulfide-bonded polymer hydrogel capsules for Doxorubicin delivery to colorectal cancer cells.
Yan Y; Johnston AP; Dodds SJ; Kamphuis MM; Ferguson C; Parton RG; Nice EC; Heath JK; Caruso F
ACS Nano; 2010 May; 4(5):2928-36. PubMed ID: 20420377
[TBL] [Abstract][Full Text] [Related]
16. Characterization of posttranslational modifications of human A33 antigen, a novel palmitoylated surface glycoprotein of human gastrointestinal epithelium.
Ritter G; Cohen LS; Nice EC; Catimel B; Burgess AW; Moritz RL; Ji H; Heath JK; White SJ; Welt S; Old LJ; Simpson RJ
Biochem Biophys Res Commun; 1997 Jul; 236(3):682-6. PubMed ID: 9245713
[TBL] [Abstract][Full Text] [Related]
17. Specific tumour localisation of a huA33 antibody--carboxypeptidase A conjugate and activation of methotrexate-phenylalanine.
Deckert PM; Bornmann WG; Ritter G; Williams C; Franke J; Keilholz U; Thiel E; Old LJ; Bertino JR; Welt S
Int J Oncol; 2004 May; 24(5):1289-95. PubMed ID: 15067353
[TBL] [Abstract][Full Text] [Related]
18. Toward therapeutic delivery with layer-by-layer engineered particles.
Yan Y; Such GK; Johnston AP; Lomas H; Caruso F
ACS Nano; 2011 Jun; 5(6):4252-7. PubMed ID: 21612259
[TBL] [Abstract][Full Text] [Related]
19. Targeted lipid-coated nanoparticles: delivery of tumor necrosis factor-functionalized particles to tumor cells.
Messerschmidt SK; Musyanovych A; Altvater M; Scheurich P; Pfizenmaier K; Landfester K; Kontermann RE
J Control Release; 2009 Jul; 137(1):69-77. PubMed ID: 19306900
[TBL] [Abstract][Full Text] [Related]
20. Functional multilayered capsules for targeting and local drug delivery.
Matsusaki M; Akashi M
Expert Opin Drug Deliv; 2009 Nov; 6(11):1207-17. PubMed ID: 19831583
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
